Year To Quarter End Statement Of Income

K Pharma,Inc. - Filing #7538109

Concept 2023-01-01 to
2023-09-30
Year to quarter end statement of income
Statement of income
Net sales
1,000,000,000 JPY
Cost of sales
90,000,000 JPY
Gross profit (loss)
910,000,000 JPY
Selling, general and administrative expenses
394,163,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
515,836,000 JPY
Non-operating income
Interest income
16,000 JPY
Non-operating income
16,000 JPY
Non-operating expenses
Non-operating expenses
7,283,000 JPY
Ordinary profit (loss)
508,569,000 JPY
Extraordinary losses
Impairment losses
36,497,000 JPY
Extraordinary losses
36,497,000 JPY
Profit (loss) before income taxes
472,072,000 JPY
Income taxes - current
73,859,000 JPY
Income taxes
73,859,000 JPY
Profit (loss)
398,213,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.